FDA approves allergy drug to lessen severity of reactions to peanuts, dairy, other foods

Feb 21, 2024 04:30 EST

The U.S. Food and Drug Administration has given the injectable Xolair (omalizumab) the green light for use in decreasing the risk of life-threatening reactions to certain foods. Doctors weighed in.

Comments

FDA approves allergy drug to lessen severity of reactions to peanuts, dairy, other foods

Read Next